Thanks Allan for giving it the "old college try" but your article couldn't get CTIX to $2.00 a share. I assume you had a tickler message in your files to write a CTIX update in July following your "stock of the year" prognostication and $13.00 by year end. I know people don't like to hear this, but I will repeat my suggestions for CTIX . . . not being negative, just seeing what works in the real world. If you think CTIX goes from $1.90 to $25, $50, $100 overnight, it's not happening.Sorry to tell those people who think Prurisol is going to be a huge share price mover in the next month or so . . . not likely to happen either. I once again suggest to Leo . . .CTIX needs to uplist to a real market. I don't even care if he has to do a R/S to meet the uplisting financial requirements or wait for Kevetrin Phase 1 results in Q1 2014 to get CTIX up a few bucks.This includes putting together a board of directors. The BOD will add credibility for institutional investors. Once uplisted, Leo needs to sell CTIX to major institutional investors . . . yes, Baker Bros, Perceptive, Orbimed, Deerfield, etc. CTIX not moving north without institutional investors . . . period.